Cobalis appoints new CEO
This article was originally published in Scrip
The US specialty pharmaceutical company Cobalis has appointed Martin Marion CEO. Mr Marion served as Cobalis's chief marketing officer between 2003 and 2006 and was a consultant to the company ahead of the launch of its OTC pre-histamine product PreHistin. Mr Marion will oversee the accelerated marketing of PreHistin and the coordination of Cobalis's other revenue-generating programmes. He has previously served as director of business development for Grey Advertising/ Grey Direct and vice-president of strategic planning and business development for DMB&B's healthcare and pharmaceutical marketing division Medicus.